| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-08 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-08 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-07 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |